| Mark DE JONG; William Diamond; Linda Lin; Vinay NAGARKAL; Christopher REGIER et al. (2015). Production of molybdenum-99 using electron beams. Patent Number: AU2014271174. |
|
Patent |
Materials |
| Regier Christopher; Ullrich Douglas; Lin Linda; de jong Mark; Nagarkal Vinay et al. (2017). produção de molibdênio-99 usando feixes de elétrons. Patent Number: BR112015029336. |
|
Patent |
Materials |
| William Diamond; Vinay NAGARKAL; Mark de JONG; Christopher REGIER; Linda Lin et al. et al. (2019). Apparatus for production of molybdenum-99. Patent Number: IL242695. |
|
Patent |
Materials |
| Douglas ULLRICH (2024). Janela de saÃda de um acelerador linear para feixe de elétrons, para uso na produção de radioisótopos, sistemas e métodos. Patent Number: BR112019015503. |
|
Patent |
Materials |
| Douglas ULLRICH (2019). Exit window for electron beam in isotope production. Patent Number: AU2018212953. |
|
Patent |
Materials |
| William Diamond; Vinay NAGARKAL; Mark de JONG; Christopher REGIER; Linda Lin et al. (2017). Production of molybdenum-99 using electron beams. Patent Number: US20170301426. |
|
Patent |
Materials |
| William Diamond; Vinay NAGARKAL; Mark de JONG; Christopher REGIER; Linda Lin et al. (2018). Production of molybdenum-99 using electron beams. Patent Number: US20180102196. |
|
Patent |
Materials |
| William Diamond; Vinay NAGARKAL; Mark de JONG; Christopher REGIER; Linda Lin et al. (2014). Production of molybdenum-99 using electron beams. Patent Number: US20140348284. |
|
Patent |
|
| Serrano-Negron, J.E.; King, D.T.; Vocadlo, D.J. (2022). Homocitrullinated beta-lactamase OXA-48. Protein Data Bank: 7lxg. |
CMCF, CMCF-ID |
PDB Deposition |
Health |
| Mosimann, W.A.; Strynadka, N.C.J.; Worrall, L.J. (2026). Staphylococcus aureus serine/threonine kinase Stk1 with inhibitor GW779439X. Protein Data Bank: 9ymt. |
CMCF-BM |
PDB Deposition |
Agriculture |
| Merchant, R.R.; Chernyak, N.; Lopez, J.A.; Sharp, P.P.; Mandal, M. et al. (2026). N-Alkyl & N-Aryl Aminopyrazole Spirocarbamates: A Two-Pronged Lead Optimization Strategy to Identify Orally Bioavailable Plasma Kallikrein Inhibitors Compound 13 ((3'R)-1'-{5-amino-1-[(2S)-1,1,1-trifluorobutan-2-yl]-1H-pyrazole-4-carbonyl}-6-chloro-5-fluorospiro[[3,1]benzoxazine-4,3'-piperidin]-2(1H)-one). Protein Data Bank: 10qs. |
CMCF-BM |
PDB Deposition |
Materials |
| Palte, R.L.; Eddins, M.; Vara, B.A.; Schneider, S.E. (2026). Crystal structure of TEAD2 with non-covalent aryl ether inhibitor.. Protein Data Bank: 9yk2. |
CMCF-BM |
PDB Deposition |
Health |
| Tran, N.; Holyoak, T. (2026). Crystal structure of the Streptococcus pneumoniae HtrA protease PDZ domain. Protein Data Bank: 9pno. |
CMCF-BM |
PDB Deposition |
Health |
| Di Lello, P.; Wells, M.M. (2026). Targeting PTPN22 at non-orthosteric binding sites - a fragment approach. Protein Data Bank: 9yg3. |
CMCF-BM |
PDB Deposition |
Agriculture |
| Di Lello, P.; Wells, M.M. (2026). Targeting PTPN22 at non-orthosteric binding sites - a fragment approach. Protein Data Bank: 9yg1. |
CMCF-BM |
PDB Deposition |
Agriculture |